Search Menu

Home
HTB
2006
March
08

8 March 2006

Contents

Antiretrovirals

Treatment-naive trial of tipranavir discontinues highest dose arm

HTB RSS

Early access

Promising data for multipurpose technologies to prevent HIV and pregnancy 24 February 2021
Community murals in Soweto on dolutegravir-based ART: an i-Base collaboration 22 February 2021
Timothy Ray Brown: a virtual memorial 21 February 2021
Main COVID-19 variants and their likely impacts on vaccines 16 February 2021
All early access reports

Current issues

February 2021
January 2021
December 2020
Back issues

Special report

Early results report 90% efficacy with from Pfizer/BioNTech COVID vaccine 11 November 2020

More from HTB

Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage

Home

i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

This site complies with the HONcode standard for trustworthy health information.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links: HIV positive; Advocate; Professional; Donate; Feedback

Advice and information: Q and A; Phoneline; Pocket info; Guides; HIV meds; Glossary

Research and conference reports: HTB; HTB South; Pipeline report

Publications and resources: Publications; Other resources; Translations; Slide sets; Order and subscribe

News and updates: News; Blogs

Advocates' network: UK-CAB; Training manual

i-Base: About us; Contact; Sitemap; Home

Find us on Facebook